Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.47 |
| ▸ | LTA4H | P09960 | 1/20 | 0.46 |
| ▸ | SYK | P43405 | 1/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | HPGD | P15428 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | PPARA | Q07869 | 1/20 | 0.43 |
| ▸ | SLC15A1 | P46059 | 1/20 | 0.42 |
| ▸ | POLB | P06746 | 2/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | CASP3 | P42574 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 1/20 | 0.41 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.41 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.41 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | CDC25B | P30305 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18953153 | 1.00 | ALDH1A1 (0.47) | ALDH1A1L3MBTL1MAPK1LTA4HSYK | |
| SCHEMBL4536083 | 1.00 | ALDH1A1 (0.47) | ALDH1A1L3MBTL1MAPK1LTA4HSYK | |
| SCHEMBL28531197 | 0.96 | ALDH1A1 (0.49) | ALDH1A1L3MBTL1MAPK1LTA4HSYK | |
| SCHEMBL28525631 | 0.91 | LTA4H (0.46) | ALDH1A1L3MBTL1MAPK1LTA4HSYK | |
| SCHEMBL20943303 | 0.88 | ALDH1A1 (0.46) | ALDH1A1L3MBTL1MAPK1LTA4HSYK | |
| SCHEMBL22465650 | 0.86 | ALDH1A1 (0.45) | ALDH1A1L3MBTL1MAPK1LTA4HSYK | |
| SCHEMBL24591298 | 0.86 | ALDH1A1 (0.47) | ALDH1A1L3MBTL1MAPK1LTA4HSYK | |
| SCHEMBL8226793 | 0.86 | ALDH1A1 (0.47) | ALDH1A1L3MBTL1MAPK1LTA4HSYK | |
| SCHEMBL24602777 | 0.86 | ALDH1A1 (0.47) | ALDH1A1L3MBTL1MAPK1LTA4HSYK | |
| SCHEMBL12156576 | 0.86 | ALDH1A1 (0.47) | ALDH1A1L3MBTL1MAPK1LTA4HSYK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250170237-A1 | MURAMYL DIPEPTIDES AND PROCESS FOR PREPARATION THEREOF | UNIVERSITEIT GENT (BE) | 2025-05-29 | — | — | US | disclosed |
| WO-2025027624-A1 | CYCLIC GLYCOLIPOPEPTIDE VACCINE ADJUVANTS AND THE PROCESS FOR PREPARATION THEREOF | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH AN INDIAN REGISTERED BODY INCORPORATED UNDER THE REGN. OF SOC. ACT (ACT XXI OF 1860) (IN) | 2025-02-06 | — | — | WO | disclosed |
| EP-4482849-A1 | MURAMYL DIPEPTIDES AND PROCESS FOR PREPARATION THEREOF | Council of Scientific & Industrial Research (IN) | 2025-01-01 | — | — | EP | disclosed |
| US-12134664-B2 | Muramyl peptide derivatives | BHARAT BIOTECH INTERNATIONAL LTD. (IN) | 2024-11-05 | — | — | US | disclosed |
| WO-2023161962-A1 | MURAMYL DIPEPTIDES AND PROCESS FOR PREPARATION THEREOF | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2023-08-31 | — | — | WO | disclosed |
| EP-3389643-B1 | NOVEL MURAMYL PEPTIDE DERIVATIVE COMPOUND, SYNTHESIS AND USES THEREOF | BHARAT BIOTECH INT LTD (IN) | 2023-05-03 | — | — | EP | disclosed |
| EP-3387005-B1 | NOVEL MURAMYL PEPTIDE DERIVATIVE COMPOUND, SYNTHESIS AND USES THEREOF | BHARAT BIOTECH INT LTD (IN) | 2022-08-24 | — | — | EP | disclosed |
| US-20220056080-A1 | Muramyl Peptide Derivatives | BHARAT BIOTECH INTERNATIONAL LIMITED (IN) | 2022-02-24 | — | — | US | disclosed |
| US-10927147-B2 | Muramyl peptide derivative compound, synthesis and uses thereof | BHARAT BIOTECH INTERNATIONAL LIMITED (IN) | 2021-02-23 | — | — | US | disclosed |
| US-10576147-B2 | Muramyl peptide derivative compound, synthesis and uses thereof | BHARAT BIOTECH INTERNATIONAL LIMITED (IN) | 2020-03-03 | — | — | US | disclosed |
| CN-108884132-A | Novel muramyl peptide derivative compound, its synthesis and application thereof | 巴拉特生物技术国际有限公司 | 2018-11-23 | — | — | CN | disclosed |
| CN-108883080-A | Novel muramyl peptide derivative compounds, their synthesis and use thereof | 巴拉特生物技术国际有限公司 | 2018-11-23 | — | — | CN | disclosed |
| EP-3389643-A1 | NOVEL MURAMYL PEPTIDE DERIVATIVE COMPOUND, SYNTHESIS AND USES THEREOF | Bharat Biotech International Limited (IN) | 2018-10-24 | — | — | EP | disclosed |
| EP-3387005-A1 | NOVEL MURAMYL PEPTIDE DERIVATIVE COMPOUND, SYNTHESIS AND USES THEREOF | Bharat Biotech International Limited (IN) | 2018-10-17 | — | — | EP | disclosed |
| WO-2017103944-A1 | NOVEL MURAMYL PEPTIDE DERIVATIVE COMPOUND, SYNTHESIS AND USES THEREOF | BHARAT BIOTECH INTERNATIONAL LIMITED (IN) | 2017-06-22 | — | — | WO | disclosed |
| WO-2017098529-A1 | NOVEL MURAMYL PEPTIDE DERIVATIVE COMPOUND, SYNTHESIS AND USES THEREOF | BHARAT BIOTECH INTERNATIONAL LIMITED (IN) | 2017-06-15 | — | — | WO | disclosed |
| US-8946224-B2 | Substituted [1,2,4]triazolo[4,3-A]pyrazines for medicaments and pharmaceutical compositions | REDX PHARMA LIMITED (GB) | 2015-02-03 | — | — | US | disclosed |
| EP-2638007-A2 | DRUG DERIVATIVES | Redx Pharma Limited (GB) | 2013-09-18 | — | — | EP | disclosed |
| US-20130225594-A1 | DRUG DERIVATIVES | REDX PHARMA PLC (GB) | 2013-08-29 | — | — | US | disclosed |
| WO-2012063085-A2 | DRUG DERIVATIVES | REDX PHARMA LIMITED (GB) | 2012-05-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220056080-A1 | Muramyl Peptide Derivatives | NOD2, NGLY1, LNPEP | ALDH1A1 4849/4885L3MBTL1 3282/4885MAPK1 1159/4885 |
| US-20130225594-A1 | DRUG DERIVATIVES | SQOR, NQO1, CYP2D6 | ALDH1A1 76/4885L3MBTL1 4166/4885MAPK1 2849/4885 |
| US-12134664-B2 | Muramyl peptide derivatives | NOD2, NGLY1, LNPEP | ALDH1A1 4849/4885L3MBTL1 3282/4885MAPK1 1159/4885 |
| US-10576147-B2 | Muramyl peptide derivative compound, synthesis and uses thereof | NOD2, HM13, QRFPR | ALDH1A1 4868/4885L3MBTL1 2566/4885MAPK1 807/4885 |
| US-20250170237-A1 | MURAMYL DIPEPTIDES AND PROCESS FOR PREPARATION THEREOF | NOD2, NOD1, TLR9 | ALDH1A1 4872/4885L3MBTL1 3516/4885MAPK1 2758/4885 |
| US-10927147-B2 | Muramyl peptide derivative compound, synthesis and uses thereof | NOD2, TLR9, MICA | ALDH1A1 4859/4885L3MBTL1 3921/4885MAPK1 960/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.